OBJECTIVE: We investigated the role of protein tyrosine phosphatase ζ (Ptprz1) in human renal cell carcinoma (RCC) cells' proliferation and associations between Ptprz1 expression and von Hippel-Lindau (VHL) activation. METHODS: A normal human renal cell line and four human RCC cell lines were used in this study. VHL or Ptprz1 expression in RCC cells was increased by transfection with a VHL or Ptprz1 vector. VHL or Ptprz1 expression was decreased in these cells by siRNA using Lipofectamine 2000. Cells' proliferative activity was assessed by WST-1 assay. RESULTS: Our results suggested that Ptprz1 was a target of VHL, and a loss of VHL activation increased Ptprz1 expression in RCC cells. Ptprz1 enhanced β-catenin protein expressions in the nuclear fractions of RCC cells and participated in regulating proliferation by activating β-catenin and its downstream genes. In addition, a loss of VHL activity may enhance the proliferative activity of RCC cells by increasing Ptprz1 expression. CONCLUSION: Ptprz1-enhanced RCC cells' proliferation depends on VHL inactivation, and the Ptprz1/β-catenin pathway may be a potential target for treating RCC with inactive VHL.
OBJECTIVE: We investigated the role of protein tyrosine phosphatase ζ (Ptprz1) in humanrenal cell carcinoma (RCC) cells' proliferation and associations between Ptprz1 expression and von Hippel-Lindau (VHL) activation. METHODS: A normal human renal cell line and four human RCC cell lines were used in this study. VHL or Ptprz1 expression in RCC cells was increased by transfection with a VHL or Ptprz1 vector. VHL or Ptprz1 expression was decreased in these cells by siRNA using Lipofectamine 2000. Cells' proliferative activity was assessed by WST-1 assay. RESULTS: Our results suggested that Ptprz1 was a target of VHL, and a loss of VHL activation increased Ptprz1 expression in RCC cells. Ptprz1 enhanced β-catenin protein expressions in the nuclear fractions of RCC cells and participated in regulating proliferation by activating β-catenin and its downstream genes. In addition, a loss of VHL activity may enhance the proliferative activity of RCC cells by increasing Ptprz1 expression. CONCLUSION:Ptprz1-enhanced RCC cells' proliferation depends on VHL inactivation, and the Ptprz1/β-catenin pathway may be a potential target for treating RCC with inactive VHL.
Authors: Marcella M Baldewijns; Iris J H van Vlodrop; Peter B Vermeulen; Patricia M M B Soetekouw; Manon van Engeland; Adriaan P de Bruïne Journal: J Pathol Date: 2010-06 Impact factor: 7.996
Authors: Miguel A Esteban-Barragán; Pilar Avila; Miguel Alvarez-Tejado; M Dolores Gutiérrez; Angeles García-Pardo; Francisco Sánchez-Madrid; Manuel O Landázuri Journal: Cancer Res Date: 2002-05-15 Impact factor: 12.701
Authors: Ossia M Eichhoff; Ashani Weeraratna; Marie C Zipser; Laurence Denat; Daniel S Widmer; Mai Xu; Lydia Kriegl; Thomas Kirchner; Lionel Larue; Reinhard Dummer; Keith S Hoek Journal: Pigment Cell Melanoma Res Date: 2011-06-09 Impact factor: 4.693
Authors: Sheila Harroch; Glaucia C Furtado; Wolfgang Brueck; Jack Rosenbluth; Juan Lafaille; Moses Chao; Joseph D Buxbaum; Joseph Schlessinger Journal: Nat Genet Date: 2002-09-30 Impact factor: 38.330